Back to dashboard
MedicaidAdministrativeMedium impact

Provider Bulletin 11-26-2025 DEA Announces Three New Telemedicine Rules IM IE LA SAC SD

Molina Healthcare·CA · Psychiatry, Pain Management, Family Medicine +2 more·Provider Bulletin
Effective date
Not stated
We identified it
Jun 19, 2026
Days to comply

Summary

The DEA has announced three new permanent telemedicine rules that allow providers to prescribe controlled substances via telemedicine under specific conditions, including expanded buprenorphine treatment access and new special registration requirements for Schedule II-V medications.

Action Required

Action needed
Before December 2025: Providers prescribing controlled substances via telemedicine must review new DEA requirements and determine if special registrations are needed. Update telemedicine protocols to ensure compliance with patient evaluation requirements. Contact Molina Provider Relations Representative for guidance on implementation.